Yann Lamotte

Title: Inventor Yann Lamotte: Pioneering Quinolinone Derivatives

Introduction

Yann Lamotte, an innovative inventor based in Les Ulis, France, has made significant contributions to the pharmaceutical field with a focus on quinolinone derivatives. With three patents to his name, his work primarily revolves around compounds that play a crucial role in medical applications, particularly as activators of AMPK.

Latest Patents

Lamotte's latest patents focus on quinolinone derivatives, described in compounds of the formula (I), including their salts and pharmaceutical compositions. These derivatives are recognized for their potential use in medicine, contributing to advancements in various therapeutic areas. Notably, the compounds developed by Lamotte serve as activators of AMPK, which is vital for regulating cellular energy metabolism.

Career Highlights

Yann Lamotte is currently affiliated with GlaxoSmithKline LLC, a prominent company in the pharmaceutical industry. His tenure at this organization has allowed him to leverage his expertise in developing innovative solutions to pressing medical challenges. Throughout his career, Lamotte has demonstrated a strong commitment to research and innovation, leading to his impressive patent portfolio.

Collaborations

While working at GlaxoSmithKline, Lamotte collaborates with distinguished colleagues such as Olivier Mirguet and Alain Claude-Marie Daugan. These collaborations are pivotal in advancing the research and development of new pharmaceuticals, showcasing the importance of teamwork in the field of innovation.

Conclusion

Yann Lamotte exemplifies the spirit of innovation within the pharmaceutical sector through his work on quinolinone derivatives. His contributions not only enhance medical research but also provide valuable solutions for various therapeutic needs. As he continues to work alongside esteemed professionals at GlaxoSmithKline, the impact of his inventions is expected to grow, paving the way for future advancements in medicine.